1 year return (CAGR)
84.01%
Akero Therapeutics Inc Exchange (NASDAQ, USD)
AKRO
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
4.50B
Price/Sales
214748.36
Ent value
4.37B
Price/Book
4.70
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
5.28%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 54.52 |
| Daily high | 54.83 |
| Daily low | 54.42 |
| Daily Volume | 11.6M |
| 1y analyst estimate | 56.50 |
| Beta | -0.40 |
| EPS (TTM) | -3.57 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 12 Mar 2026 |
Downside potential
Loading...
Downside potential data
| AKRO | S&P500 | |
| Current price drop from All-time high | -5.06% | -0.63% |
| Highest price drop | -61.55% | -56.47% |
| Date of highest drop | 14 Jan 2025 | 9 Mar 2009 |
| Avg drop from high | -23.72% | -10.68% |
| Avg time to new high | 293 days | 12 days |
| Max time to new high | 213 days | 1805 days |
News
No items found